Pfizer Inc. (PFE)
SIX
Real-time Data
07:00 AM
Day's Range
22.5052 wk Range
19.19Overview - PFE - Pfizer Inc.
Key Statistics
Valuation
Enterprise Value
144.08B
P/E (Trailing)
‪36.29‬
PEG Ratio
‪-0.33‬
Price / Sales (TTM)
‪2.01‬
Price / Book
‪1.88‬
EV / EBITDA
‪7.10‬
Profitability
Gross Margin
‪72.78%‬
Profit Margin
‪6.80%‬
Operating Margin
‪27.87%‬
Return on Assets
‪5.78%‬
Return on Equity
‪5.01%‬
Ownership
Shares Outstanding
5.69B
Float
5.69B
Held by Insiders
‪0.10%‬
Held by Institutions
‪69.13%‬
Price stats
Beta
‪0.28‬
50-Day Avg
‪20.43‬
200-Day Avg
‪20.97‬
Dividends
Payout Ratio
‪113.16%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PFE - Pfizer Inc.
Peers - PFE - Pfizer Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on SIX.
Profile Summary - PFE - Pfizer Inc.
About
Pfizer Inc. is a leading biopharmaceutical company that discovers, develops, manufactures, markets, distributes, and sells prescription drugs and vaccines worldwide. Operating in segments including Biopharma, PC1, and Pfizer Ignite, it focuses on key therapeutic areas such as oncology, cardiology, immunology, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
